RELYLO
Glaxo Group Limited
| Research |
OneLook
Acronym Finder
|
| Serial Number | 78606898 |
| Registration Number | 3106356 |
| Mark Drawing Code | 4000: Illustration: Drawing with word(s)/letter(s)/number(s) in Block form |
| Cancellation Code | 2 |
| Domestic Representative | Maribeth Day Case |
| Attorney Name | Maribeth Day Case |
| Law Office Assigned | M10 |
| Employee Name | CLYBURN, CARLA DIONNE |
Timeline
| 2005-04-12 | Application Filed |
| 2006-03-28 | Published for Opposition |
| 2006-06-20 | Location: PUBLICATION AND ISSUE SECTION |
| 2006-06-20 | Trademark Registered |
| 2013-01-25 | Cancelled |
| 2013-01-25 | Status: Dead/Cancelled |
| 2018-07-08 | Transaction Date |
Trademark Applicants & Owners
| Owner: |  Glaxo Group Limited |
| Address | Glaxo Wellcome House Berkeley Avenue Greenford Middlesex GB UB6 0NN GB2 |
| Legal Entity Type | Corporation |
| Legal Entity State | GB |
Documents
Click the blue "Refresh" button to load certificates, specimines, application, and other documents.
Attorney of Record
Good, Services, and Codes
| International Codes: | 5 |
| U.S. Codes: | 006,018,044,046,051,052 |
| Type Code | Type |
|---|---|
| GS0051 | PHARMACEUTICAL PREPARATIONS AND SUBSTANCES FOR THE TREATMENT OF INFECTIOUS DISEASES, PAIN, INFLAMMATION, SEPSIS, ALOPECIA AND OBESITY, AND FOR THE TREATMENT OF VIRAL, METABOLIC, MUSCULOSKELETAL, CARDIOVASCULAR, CARDIOPULMONARY, GENITOURINARY, SEXUAL DYSFUNCTION, ONCOLOGICAL, RESPIRATORY, NEUROLOGICAL, GASTROINTESTINAL, HORMONAL, DERMATOLOGICAL AND PSYCHIATRIC RELATED DISEASES AND DISORDERS AND FOR THE TREATMENT OF DAMAGED SKIN AND TISSUE; AND FOR VACCINES |
Trademark Filing History
| Description | Date | Event Coding |
|---|---|---|
| NEW APPLICATION ENTERED IN TRAM | 2005-04-19 | 1 NWAP I:Incoming Correspondence |
| ASSIGNED TO EXAMINER | 2005-11-09 | 2 DOCK D:Assigned to Examiner |
| NON-FINAL ACTION WRITTEN | 2005-11-18 | 3 CNRT R:Renewal |
| NON-FINAL ACTION MAILED | 2005-11-21 | 4 CNRT F:First Action |
| TEAS RESPONSE TO OFFICE ACTION RECEIVED | 2006-01-06 | 5 TROA I:Incoming Correspondence |
| CORRESPONDENCE RECEIVED IN LAW OFFICE | 2006-01-06 | 6 CRFA I:Incoming Correspondence |
| TEAS/EMAIL CORRESPONDENCE ENTERED | 2006-01-20 | 7 TEME I:Incoming Correspondence |
| APPROVED FOR PUB - PRINCIPAL REGISTER | 2006-02-02 | 8 CNSA O:Outgoing Correspondence |
| ASSIGNED TO LIE | 2006-02-10 | 9 ALIE A:Allowance for Publication |
| LAW OFFICE PUBLICATION REVIEW COMPLETED | 2006-02-14 | 10 PREV O:Outgoing Correspondence |
| NOTICE OF PUBLICATION | 2006-03-08 | 11 NPUB O:Outgoing Correspondence |
| PUBLISHED FOR OPPOSITION | 2006-03-28 | 12 PUBO A:Allowance for Publication |
| REGISTERED-PRINCIPAL REGISTER | 2006-06-20 | 13 R.PR A:Allowance for Publication |
| TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | 2010-02-25 | 14 REAP I:Incoming Correspondence |
| ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | 2010-02-25 | 15 ARAA I:Incoming Correspondence |
| TEAS CHANGE OF CORRESPONDENCE RECEIVED | 2010-05-13 | 16 TCCA I:Incoming Correspondence |
| CANCELLED SEC. 8 (6-YR) | 2013-01-25 | 17 C8.. O:Outgoing Correspondence |
Similar Marks
Mark Image Registration | Serial | Company Trademark Application Date |
|---|---|
 RELYLO 85583753 not registered Dead/Abandoned |
Glaxo Group Limited 2012-03-29 |
 RELYLO 78606898 3106356 Dead/Cancelled |
Glaxo Group Limited 2005-04-12 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 